As of 2025-06-02, the EV/EBITDA ratio of Global Pharmatech Inc (GBLP) is -55.66. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBLP's latest enterprise value is 83.04 mil USD. GBLP's TTM EBITDA according to its financial statements is -1.49 mil USD. Dividing these 2 quantities gives us the above GBLP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 31.6x | 26.3x |
| Forward P/E multiples | 21.0x - 31.6x | 26.3x |
| Fair Price | (0.08) - (0.11) | (0.09) |
| Upside | -137.8% - -156.7% | -147.3% |
| Date | EV/EBITDA |
| 2025-03-11 | -67.35 |
| 2025-03-06 | -77.89 |
| 2025-03-05 | -65.68 |
| 2025-03-04 | -69.57 |
| 2025-02-28 | -69.57 |
| 2025-02-27 | -42.02 |
| 2025-02-26 | -42.02 |